Surgitate
Kocaeli
About Surgitate
Surgitate fabricates synthetic models that surgeons, medical and veterinary students, and other medical staff such as nurses and obstetricians can practice on. Their models are designed to create a realistic feel of incision, dissection, and suturing. Their cofounders are a materials engineer (Ozge Akbulut, PhD) and a thoracic surgeon (Bark─▒n Eldem, MD). Surgitate has two investors: Farplas, leading plastic automotive parts manufacturer in Turkey, and Inovent, Turkey’s first technology commercialization/accelerator and seed funding company. They rely on expertise of Farplas in process development, molding, and painting for the mass scale production of synthetic body parts. Inovent assures that we are well-connected to our potential investors and customers; and handles business and marketing plans.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $81.9K
- Funding stage: Seed
- Last round: Grant (Jan 2019)
- Website: surgitate.com
- Phone: +90 5332472920
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/surgitate-182711 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.